Anorexia News and Research

RSS
CHOP study: Children with specific gene variants may require higher doses of pain-control drugs

CHOP study: Children with specific gene variants may require higher doses of pain-control drugs

Merck reports results from global EMEND Phase 3 study for CINV prevention in pediatric cancer patients

Merck reports results from global EMEND Phase 3 study for CINV prevention in pediatric cancer patients

Helsinn Group grants GEN Ilaç anamorelin rights for Turkey

Helsinn Group grants GEN Ilaç anamorelin rights for Turkey

Research finds food addicts lacking psychological inhibition

Research finds food addicts lacking psychological inhibition

Emily Program plans to open new office in Olympia

Emily Program plans to open new office in Olympia

Amgen presents extended analysis of PEAK study data at ASCO

Amgen presents extended analysis of PEAK study data at ASCO

RDT receives FDA approval for new liquid form of treatment for patients with ALL

RDT receives FDA approval for new liquid form of treatment for patients with ALL

Oral health: The gateway to your overall health

Oral health: The gateway to your overall health

UT Southwestern researchers identify potential new treatment for depression

UT Southwestern researchers identify potential new treatment for depression

Eating Recovery Center collaborates with Eating Disorder Center at San Antonio

Eating Recovery Center collaborates with Eating Disorder Center at San Antonio

Brain disconnect leaves teen brain less able to judge trustworthiness

Brain disconnect leaves teen brain less able to judge trustworthiness

Bayer and Onyx announce Phase 3 trial evaluating use of NEXAVAR for patients with HCC after local ablation

Bayer and Onyx announce Phase 3 trial evaluating use of NEXAVAR for patients with HCC after local ablation

GW SPHHS to hold public forum on prevalence and impact of eating disorders

GW SPHHS to hold public forum on prevalence and impact of eating disorders

Celgene subsidiary presents REVLIMID study results on lymphoma at ASH annual meeting

Celgene subsidiary presents REVLIMID study results on lymphoma at ASH annual meeting

Janssen reports positive pivotal Phase 2 study data of siltuximab for Multicentric Castleman's Disease

Janssen reports positive pivotal Phase 2 study data of siltuximab for Multicentric Castleman's Disease

Soligenix initiates orBec Phase 2 study for GI manifestations of chronic GVHD

Soligenix initiates orBec Phase 2 study for GI manifestations of chronic GVHD

NEXAVAR tablets receive FDA approval for treatment of patients with thyroid cancer

NEXAVAR tablets receive FDA approval for treatment of patients with thyroid cancer

Study identifies patterns of brain activity associated with eating disorders

Study identifies patterns of brain activity associated with eating disorders

Helsinn grants exclusive commercialization rights to Chugai Pharma Marketing for anamorelin drug

Helsinn grants exclusive commercialization rights to Chugai Pharma Marketing for anamorelin drug

Researchers highlight presence of specific antibodies that regulate appetite in obese patients

Researchers highlight presence of specific antibodies that regulate appetite in obese patients